Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, ...

May 12 (Reuters) - Roche Group (ROG.S), opens new tab said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

Roche and Genentech to spend $700 million building new manufacturing facility May 12, 2025 by Mai Tao Genentech , a ...

Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The planned Holly Springs facility, spanning 700,000 ...